Brief: GeoVax Announces Initiation Of Phase 2 Clinical Trial Of COVID-19 Vaccine Booster In Patients With Chronic Lymphocytic Leukemia
20/07/2023 14:13
July 20 (Reuters) - GeoVax Labs Inc GOVX.O :
* GEOVAX ANNOUNCES INITIATION OF PHASE 2 CLINICAL TRIAL OF
COVID-19 VACCINE BOOSTER IN PATIENTS WITH CHRONIC LYMPHOCYTIC
LEUKEMIA
Source text for Eikon: ID:nGNX5X54bL
Further company coverage: GOVX.O